New Guidance on Cervical Cancer Screening from USPSTF, American Cancer Society
March 23, 2012 | Strategic Insights for Ambulatory Care
New guidance from the U.S. Preventive Services Task Force (USPSTF) recommends that most women can wait at least three years between cervical cancer screenings. Also for the first time, USPSTF has formally recommended cotesting as an alternative to Pap smear testing alone. The new USPSTF guidelines update recommendations from 2003, now advising cervical cancer screening in women age 21 to 65 years with cytology every three years. Additionally, USPSTF says that women age 30 to 65 years who want to lengthen the time between screenings may receive screening with a combination of cytology and human papillomavirus (HPV) testing every five years.